PA007543.r2a: In Vivo Grade Recombinant Anti-mouse LPAM-1 (Intergrin α4β7) Monoclonal Antibody (Clone: DATK32), Rat IgG2a Kappa
Recombinant Rat IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: DATK32) specifically binds to mouse LPAM-1 (Intergrin α4β7).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse LPAM-1 (Intergrin α4β7) protein.PA007581.r2a: In Vivo Grade Recombinant Anti-mouse MAdCAM-1 Monoclonal Antibody (Clone: MECA-367), Rat IgG2a Kappa
Recombinant Rat IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: MECA-367) specifically binds to mouse MAdCAM-1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse MAdCAM-1 protein.PA005314-ANT-340: CD29 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: ELISA, WB;
Reactivity: Human;
Clone: Pk2D5AT;
Isotype: Mouse IgG1.BP002797-ENZ-600: Recombinant Human Glutathione S-Transferase Alpha 4 (GSTA4) Enzyme
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.C055P: Natalizumab Biosimilar, Integrin alpha 4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade natalizumab biosimilar specifically binds to the human Integrin α4.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by natalizumab.C065P: Volociximab Biosimilar (Research Grade), Anti-human Integrin α5β1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade volociximab biosimilar specifically binds to the human integrin α5β1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by volociximab.